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Abstract.  &Catenin  is involved in the formation of 
adherens junctions of mammalian  epithelia.  It interacts 
with the cell adhesion  molecule E-cadherin  and also 
with the tumor suppressor gene product APC,  and the 
Drosophila homologue of B-catenin,  armadillo,  medi- 
ates morphogenetic signals.  We demonstrate  here that 
E-cadherin  and APC directly compete for binding to 
the internal,  armadillo-like repeats of/5-catenin;  the 
NH2-terminal  domain of/3-catenin  mediates the inter- 
action of the alternative  E-cadherin  and APC com- 
plexes to the cytoskeleton by binding to et-catenin. 
Plakoglobin  (7-catenin),  which is structurally  related 
to/3-catenin,  mediates  identical  interactions.  We thus 
show that the APC tumor suppressor gene product 
forms strikingly  similar associations as found in cell 
junctions  and suggest that/3-catenin  and plakoglobin 
are central  regulators  of cell adhesion,  cytoskeletal in- 
teraction,  and tumor  suppression. 
I 
T recently became evident that the proper formation of 
intercellular  junctions  is  critical  for the  maintenance 
of epithelial differentiation,  and that destabilization of 
junctions  allows  invasiveness  of epithelial  cells  and  the 
progression  of carcinomas  (of.  for review Tsukita  et al., 
1993; Birchmeier et al.,  1993). Interestingly, various struc- 
tural components of intercellular junctions have been found 
to be related to products of tumor suppressor genes. For in- 
stance,  the  adherens  junction  molecule  E-cadberin  sup- 
presses invasiveness of carcinoma cells, and the E-cadherin 
gene is mutated  in 50%  of the diffuse-type gastric  carci- 
nomas (Behrens et al., 1989; Frixen et al., 1991; Vleminckx 
et al., 1991; Becker et al., 1994). The tumor suppressor gene 
product APC binds to B-catenin,  which is cytoplasmically 
associated to E-cadherin (Rubinfeld et al.,  1993; Suet al., 
1993; Nagafuchi and Takeichi,  1988; Ozawa et al.,  1989). 
The tight junction-associated protein ZO-I is related to the 
dlg tumor suppressor gene product of Drosophila,  and the 
neurofibromatosis-2  tumor  suppressor  gene product  mer- 
lin/schwannomin is related to the ezrin/radixin/moesin  fam- 
ily of junctional proteins (Woods and Bryant, 1991; Rouleau 
et al., 1993; Trofatter et al.,  1993). Conversely, products of 
oncogenes have been demonstrated to destabilize intercellu- 
lar junctions,  such as src, ms, fos, or met (Behrens et al., 
1993;  Hamaguchi  et  al.,  1993;  Behrens  et  al.,  1989; 
Shibamoto et al., 1994; Reichmann et al., 1992; Weidner et 
al.,  1990).  Src,  the EGF receptor,  and met phosphorylate 
B-catenin  on  tyrosine  residues,  which  may  modulate  the 
adhesive properties of cells. 
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Adherens junctions  of epithelial  cells are  specialized re- 
gions of the plasma membrane where transmembrane E-cad- 
herin molecules on opposing cells make contact with each 
other (Boiler et al.,  1985; Tsukita et al.,  1992; for a discus- 
sion of the related desmosomes see Garrod, 1993). The cyto- 
plasmic domain of E-cadherin forms complexes with ct-, B-, 
and 3,-catenin/plakoglobin, which are essential for the adhe- 
sive function (Nagafuchi and Takeichi,  1988; Ozawa et al., 
1989; Ozawa et al.,  1990; Kintner,  1992). ot-Catenin  shows 
sequence similarity to vinculin and interacts with the cyto- 
skeleton (Nagafuchi et al., 1991; Herrenknecht et al., 1991; 
Hirano et al., 1992). B-Catenin is the vertebrate homologue 
of the segment polarity gene armadillo of Drosophila and is 
related to plakoglobin (McCrea et al.,  1991;  Peifer et al., 
1992;  Butz et al.,  1992).  3,-Catenin  is identical to plako- 
globin, which is also found in desmosomal junctions (Cowin 
et al.,  1986; Franke et al.,  1989; Knudsen and Wheelock, 
1992; Peifer et al.,  1992; Hinck et al.,  1994a,b; Niithke et 
al.,  1994). Recent experimental evidence suggests that any 
significant change in expression or structure of one of these 
components leads to adherens junction disassembly and con- 
sequently,  to  non-adhesive  and  invasive  cells.  Molecular 
aberrations which result in such defects have been studied: 
an E-cadherin deletion mutant lacking its catenin binding re- 
gion was not functional in cell-cell adhesion when expressed 
in fibroblasts (Nagafuchi and Takeichi,  1988; Ozawa et al., 
1990).  Cadherin mutants without the extracellular domain 
acted in a dominant-negative fashion, i.e., disturbed epithe- 
lial cell adhesion  (Kintner,  1992).  Apparently,  these trun- 
cated molecules collect catenins,  which are thus not avail- 
able to form proper complexes with intact E-cadherin.  The 
adhesive properties of PC9 lung cancer ceils, which harbor 
a null mutation in the ct-catenin gene, could be restored by 
transfection  with  ct-catenin  cDNA  (Hirano  et al.,  1992). 
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ered in 50% of diffuse-type gastric carcinomas, which lead 
to shortened mRNAs  in which  exons 8  or 9  are  skipped 
(Becker et al., 1994). Mutations of  the E-cadherin gene have 
also been identified in human ovarian carcinomas and in two 
non-adhesive cell lines from gastric carcinomas (Risinger et 
al.,  1994; Oda et al.,  1994). 
Recently, the  tumor suppressor gene product APC has 
been found to associate with the adherens junction proteins 
o~- and ~-catenin (Suet al.,  1993;  Rubinfeld et al.,  1993). 
The APC gene codes for a cytoplasmic 300 kDa protein and 
is mutated in a high percentage of colon carcinomas, which 
represent 15 % of  all cancers in the United States (Fearon and 
Vogelstein,  1990).  Various  genetic  changes  during  colon 
cancer progression have been found, such as in the genes of 
APC, ras, p53, and DCC. Mutations of  the tumor suppressor 
gene APC occur early during progression of the disease. 
Furthermore, an inherited disorder exists, Familial Adeno- 
matous Polyposis,  also caused by APC  mutations,  which 
is characterized by an early onset of numerous polyps in 
the  colon which progress  to  malignancy  (Groden et al., 
1991; Kinzler et al.,  1991). Little is known, however, about 
the  functional role of APC  in colonic epithelia,  nor is it 
known why mutation of the APC gene product promotes co- 
lon cancer. 
It  was  previously unclear how  the  interaction between 
membrane-bound E-cadherin, the cytoskeleton, and the tu- 
mor suppressor gene product APC is organized on a molecu- 
lar level. There was indication that ~-catenin associates ear- 
lier than cz-catenin  to E-cadherin during biogenesis of the 
adherens junction complex, and that B-catenin is also more 
strongly bound to E-cadherin (Ozawa et al.,  1990; Hinck et 
al., 1994b). It has furthermore been shown that catenin/APC 
immunoprecipitates do not contain E-cadherin (Suet al., 
1993),  indicating that APC  and E-cadherin might not be 
bound to/~-catenin at the same time. We demonstrate here 
that APC and E-cadherin compete for binding to/3-catenin, 
and that/~-catenin and plakoglobin are direct but indepen- 
dent linkers between E-cadherin or APC and the cytoskel- 
eton-associated component ot-catenin.  We also  show that 
this link is mediated by different domains of ~-catenin, i.e., 
the  armadillo-like  repeats  bind  to  E-cadherin  and  APC 
whereas the NH2-terminal domain is required for the inter- 
action to ot-catenin. 
Materials and Methods 
cDNA Constructs and Deletion Mutants 
The human/$-catenin cDNA was isolated from a eDNA library of placenta 
(HL1075B; Clontech, Palo Alto, CA) using the Xenopus eDNA (McCrea 
et al.,  1991) as a probe. The 2,585-bp/3-catenin eDNA contains the com- 
plete coding region as well as 200- and 42-bp of 5'- and 3'-noneoding se- 
quence,  respectively (ef.  GenBank accession no.  Z19054).  The deduced 
amino acid sequence is highly similar to the Xenopus sequence (97% iden- 
tity), and identical to the mouse sequence except for one amino acid differ- 
ence at position 706 (cf. also McCrea et al.,  1991;  Butz et al.,  1992).  13 
internal repeats of about 40 amino acids in length, as originally described 
for armadillo (Peifer and Wieschaus, 1990; Peifer et al., 1994), are flanked 
by  unique  NH2-  and  COOH-terminal  sequences  of  131  and  86  amino 
acids,  respectively.  Sequence  comparisons  were  performed  using  the 
TFASTA,  MOTIF,  +TREE,  MULTalign, and CLUSTAL program pack- 
ages  of the  HUSAR-system  (European  Molecular  Biology  Laboratory, 
Heidelberg, Germany). 
The human eDNA of/~-catenin was used for the generation of deletion 
mutants (Fig.  1 A). To detect B-catenin and the mutants by immunological 
methods, a tag epitope (EQKLISEEDL, derived from human c-myc; Evan 
et al.,  1985) was added to either the NH2- or COOH-terminal side. Oligo- 
nucleotides coding for either the NH2-terminal or COOH-terminal tag plus 
respective start or  stop eodons  were  first inserted into the pBluescript 
SKII  + vector (Fig.  1 B). Deletions of ~-catenin containing appropriate re- 
strietion  sites  for  cloning  were  then  generated  by  PCR-mediated  site- 
directed mutagenesis (shown for the AN/C-term mutant in Fig.  1 C) and 
were inserted into the tag-containing vectors.  The resulting eDNA con- 
structs  were  cloned  into  the  pBAT  expression  vector  (Nagafitehi  and 
Takeichi,  1988).  The eDNAs  for mouse  E-cadherin (Nagafuehi  et al., 
1987), mouse a-catenin (Nagafuchi et al.,  1991),  and human plakoglobin 
(Franke et al.,  1989) were also used in the pBAT vector. 
The fragment of APC encoding the/3-catenin binding site (Suet  al., 
1993) was isolated from genomic DNA of human MCF7 cells by PCR using 
the primer pair 5'-CCATCCAGCAACAGAAAATCCA-3' and 5'-ACTTTT- 
GGAGGGAGATTTCGCT-3'.  A  NH2-terminal FLAG-epitope (MDYKD- 
DDDK; IBI, New Haven, CT) including a translation initiation site (Kozak, 
1986) and a stop codon were introduced at amino acid positions 957 and 
1211,  respectively, by PCR-mediated  site-directed mutagenesis using the 
primer  pair  5'-GCGCCTCTAGACCGCCA~TACAAGGACGACG- 
ACGACAAG~CCGGGAGATCTTCAAATGATAGTTTAAATA- 
GTGTCAGT-3'  and  5'-GCGCCGTCGACTATTAATGTTCGGTTTTACT- 
GC'ITII3T-3'. The resulting PCR product was introduced into the pBAT 
vector using XbaI/SalI sites. 
Cells and Immunological Methods 
The different eDNA constructs (15 #g each) were transiently transfectad 
into Neuro2A cells using the calcium phosphate method (Hartmann et al., 
1992). Neuro2A cells do not express E-cadherin, APC, or the catenins en- 
dogenously. After transfection with E-cadherin cDNA, some a- and B-cat- 
elfin protein expression was induced (ef.  Nagafuehi et al.,  1991),  which 
represents a minor amount in comparison to the exogenously expressed pro- 
teins. Furthermore, endogenous presence of catenins would not affect our 
results, since a- and/$-catenins do not form homodimers (el. below). Im- 
munodetection of the expressed proteins was carried out after two days of 
culture. Immtmofluorescence staining was performed as described (Bchrens 
et al., 1989) after fixation of the cells with methanol for 5 rain. For immtmo- 
precipitation,  Neuro2A  cells  were  labeled  overnight  with  20  #Ci/ml 
[35Slmethionine one day after tramfection, and cells were then extracted 
with  140 mM NaCI,  4.7 mM KC1, 0.7 mM MgSO4,  1.2 mM CaCI2,  I0 
mM Hepes, pH 7.4, containing 1% Triton X-100, and 1 mM phenylmethyl 
sulfonylfluorid. After ultracentrifugetion at 100,000 g, the appropriate anti- 
bodies and protein A-Sepharose were added, and precipitates were washed 
with 100 m.M NaCI, 5 mM EDTA, 50 mM TrieJHCI, pH 8.0, containing 
1% Triton X-100, and 1 mg/ml ovalbumin (Behrens et al.,  1989). Western- 
blot analysis was performed using the Western-Light protocol (Tropix Inc., 
Bedford, MA). The mouse mAb MyeI-9E10 (Evan et al.,  1985) was used 
to  detect  the  tag-epitope  of  the  /3-catenin  mutants,  the  mouse  mAb 
anti-FLAG M2 (IBI) to detect the FLAG-epitope of the APC fragment. 
E-eadherin was detected with DECMA-1 antibody (Vestweber and Kemler, 
1985) and plakoglobin was with mouse mAb PG5.1 (Cowin et al.,  1986). 
The anti-a-catenin  antibody was produced in rabbits  against  a synthetic 
peptide (HVNPVQALSEFK)  corresponding to 12-amino acid residues 
near  the  COOH  terminus.  The  anti-B-catenin  antibody  was  raised  in  rabbits 
against  a synthetic  peptide  (PGDSNQLAWFIYrDL)  corresponding  to the 
last  14-arnino  acid  residues  of  the COOH  terminus. 
Results 
Interaction between [3-Catenin, E-Cadherin, and APC 
We constructed  deletion  mutants of the human/3-catenin 
eDNA  that encode proteins which lack either COOH-  or 
NH2-terrninal domains or both, or which have truncations 
within the region of the 13 armadillo-like repeats (Fig.  1 A). 
In all constructs, a sequence encoding an epitope of human 
c-myc was ligated to the 5'- or 3'-termini, which served as 
a tag to identify full size or mutant B-catenin immunologi- 
cally (Fig.  1, B and C). The location of the tag-epitope did 
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representation of full-size and 
mutant  /3-catenin  and  sum- 
mary of their ability to inter- 
act with E-cadherin  or APC. 
On  the  left,  the  NH2- and 
COOH-terminal domains and 
the 13 internal armadillo-like 
repeats of/3-¢atenin  are indi- 
cated by striped and shadowed 
boxes, respectively.  The empty 
box  between  repeat  10  and 
11  indicates  a  stretch  of un- 
repeated amino acids. The fol- 
lowing  amino  acid  residues 
were  deleted  in  the  mutated 
proteins:  AC-term,  696-781; 
AN-term,  1-131; AN/C-term, 
1-131 and 696-781; ACARll- 
13, 555-781; ANAR1-3, 1-258; 
ACARS-13, 424-781; ANAR1-7, 
1-422. On the  right,  a  sum- 
mary of the  binding  studies 
between  the  13-catenin mu- 
tants and E-cadherin or APC 
is  presented.  (B)  Sequence 
of oligonucleotides  encoding 
NH2- or COOH-terminal  tag 
epitope  (underlined)  in  the 
corresponding  vectors  are 
shown.  A  Kozak  consensus 
sequence of  translational initi- 
ation  (Kozak,  1986),  stop 
codons,  and  restriction  sites 
used for cloning are indicated. 
(C) Generation of the f3-cate- 
nin deletions  exemplified for 
the AN/C-term mutant.  PCR 
products  of  the  t3-catenin 
eDNA and 5' add-on primers 
containing start and stop co- 
dons as well as suitable restric- 
tion sites for the insertion into 
the two tag-containing vectors 
(B) are shown. 
not alter the interactions  observed.  The eDNA constructs 
were  transiently  transfected  into  Neuro2A  cells  (mouse 
neuroblastoma; cf.  Hartmann et al.,  1992),  which neither 
express  E-cadherin  nor  catenin  proteins,  as  revealed  by 
immunofluorescence and Western blot experiments; the ab- 
sence of APC expression was tested by Northern blotting 
(data  not  shown).  When  the  E-cadherin  and  /3-catenin 
cDNAs were separately expressed, E-cadherin was located 
at  the  cell  membrane while  /3-catenin  was  diffusely  dis- 
tributed  throughout  the  cytoplasm,  as  revealed  by  im- 
munofluorescence staining (Fig. 2, a  and b). When the two 
cDNAs were cotransfected, both proteins were membrane- 
associated, reflecting the direct interaction of/3-catenin with 
E-cadberin. Likewise, ~-catenin lacking both the NH2- and 
COOH-terminal domains was membrane-associated in the 
presence of E-cadherin (Fig. 2 c). However, ~-catenin lack- 
ing the NH2-terminal domain plus repeat units 1 to 7 did not 
associate with E-cadherin at the cell membrane (Fig. 2 d). 
Immunoprecipitations of/~-catenin from [35S]methionine- 
labeled Neuro2A cells with anti-tag antibodies corroborated 
these results: E-cadherin was associated with full-size/~-cat- 
enin as well as with mutants lacking either the COOH- or 
NH2-terminal domain or both (Fig. 3, A and B, lanes 2-5). 
However, deletion of repeat units 1 to 3 diminished binding 
to E-cadherin, deletion of repeats 11 to 13 abolished binding 
(Fig. 3 B, lanes 6 and 7); ~-catenin with larger truncations 
of repeat units did not bind (Fig. 3 B, lanes 8 and 9; cf. also 
Fig.  1 A for a  summary). Interestingly, certain mutants of 
/~-catenin  which alone did not bind (e.g., those lacking re- 
peats 1-7 and 11-13),  were able to interact with E-cadherin 
when expressed in combination (Fig. 3 B, lanes 10 and 11 ). 
These mutant proteins directly interacted with each other 
even in the absence of E-cadherin (Fig.  3  C, lane I ).  The 
interaction was mediated by overlapping repeat regions but 
not the terminal domains, since exact halves of/~-catenin did 
not interact (Fig. 3 C, lane 2). Interestingly, we could not de- 
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localization  of  recombinant 
E-cadherin  and  B-catenin  in 
mouse  neuroblastoma  (Neu- 
ro2A)  cells  after  cotransfec- 
tion with expression constructs 
for (a) E-cadherin, (b) B-cate- 
nin, (c) E-cadhedn plus B-cat- 
enin  lacking  the  NH2-  and 
COOH-terminal  domains, and 
(d) E-cadherin plus/~-catenin 
lacking  the NH2-terminal  do- 
main and repeats  1 to 7. Stain- 
ing  was  performed  with  (a) 
anti-E-cadherin  antibody  or 
(b-d) anti-tag antibody (MycI- 
9El0;  Evan et  al.,  1985)  to 
detect ~/-catenin. Bar, 20/zm. 
tect dimerization of full-size B-catenin (Fig. 3 D). The com- 
bined  results  show:  (a)  that  interaction  of B-catenin  with 
E-cadherin is mediated by the armadillo-like repeats and not 
by the terminal domains; (b) that multiple rather than single 
repeat units are involved in the binding; and (c) that internal 
repeat units can interact with each other and thus cooperate 
in the binding to E-cadherin  (cf.  Fig.  7). 
We also identified the sequences of B-catenin that bind to 
APC and examined,  how this binding is influenced by the 
formation of the E-cadherin//$-catenin complex. A fragment 
Figure 3. (A and B) Association of (tagged) wild-type and mutant 
B-catenin with E-cadherin, as revealed by immunoprecipitation of 
[35S]methionine-labeled cell  extracts  using  anti-tag antibody (A, 
an autoradiograph is shown) followed by Western blot analysis with 
anti-E-cadherin antibody (B).  Neuro2A cells  were cotransfected 
with expression constructs for E-cadherin and the various 13-catenin 
mutants as indicated above the figure. Control, E-cadherin expres- 
sion construct alone.  The positions  of the 15-catenin mutants in A 
are marked by arrowheads,  the location of E-cadherin in B by an 
arrow. Western blotting (B) has been performed since contaminat- 
ing bands mask E-cadherin in A. Molecular weight markers are in- 
dicated.  (C) Association of ~3-catenin mutants with each other in 
the absence of E-cadherin. Neuro2A cells were transfected with the 
~/-catenin mutant ANAR1-7 alone (lane 4) or in combination with 
the mutants ACAR1M3 (lane  1) or ACAR8-13 (lanes  2 and 3). 
[35S]Methionine-labeled  cell  extracts  were  immunoprecipitated 
with anti-B-catenin antiserum (lanes 1, 2, and 4) or anti-tag anti- 
body (lane 3, to reveal expression  of both mutants).  Note that the 
anti-B-catenin antiserum does not recognize mutants lacking  the 
COOH-terminal domain.  (D)  Lack of homodimerization of full- 
size/%catenin.  Neuro2A cells were transfected with B-catenin with- 
out a tag (lane 3), ~-catenin  with a COOH-terminal tag (lane 4), 
or a combination of  both (lanes 1 and 2). Immunoprecipitation was 
carried out using the anti-/3-catenin  antiserum (lanes  1 and 3) or 
the anti-tag antibody (lanes 2 and 4), and precipitates  were ana- 
lyzed by Western  blotting  with  anti-B-catenin antiserum (top) or 
anti-tag antibody (bottom).  Specific recognition of  tagged and wild- 
type ~-catenin was possible,  since  the anti-/3-catenin  antiserum 
does not detect its epitope in the presence of a COOH-terminal tag. 
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~-catenin mutants in cotransfected  Neuro2A cells,  as revealed by 
immunoprecipitation of APC using an anti-FLAG antibody fol- 
lowed by Western blot analysis of (tagged)/~-catenin  with anti-tag 
antibody. The/3-catenin  mutants used are indicated above. Control, 
APC expression  construct alone.  The lower band in lane 3  is a 
degradation product of the AN/C-term mutant which was observed 
in some experiments.  (B) Competition between E-cadherin and the 
APC fragment for binding to/3-catenin. Neuro2A cells were trans- 
fected with 15 #g expression constructs for each APC and/$-catenin 
plus  increasing  amounts of expression  construct for E-cadherin 
(lanes 1 and 6, 0/~g; lanes 2 and 7, 1/~g; lanes 3 and 8, 2/xg; lanes 
4 and 9, 5 #g and lanes 5 and 10,  10 ftg). APC (lanes 1 to 5) and 
E-cadherin (lanes 6 to 10) were immunoprecipitated (IP) followed 
by Western  blotting  using anti-/3-catenin  antiserum (top) or anti- 
FLAG antibody against  APC (bottom). 
Figure 5.  (A) Association of recombinant u-catenin with (tagged) 
/3-catenin mutants  in cotransfected  Neuro2A cells,  as revealed by 
immunoprecipitation of [35S]methionine-labeled  cell  extracts  us- 
ing anti-tag antibody (an autoradiograph is shown). The/3-catenin 
mutants used are indicated above and their positions are marked by 
arrowheads.  Control, transfection of/3-catenin expression construct 
alone. The position of co-immunoprecipitated u-catenin is marked 
on the left side. The anti-tag antibody also recognizes an unspecific 
120-kD protein which is unrelated to E-cadherin and is also present 
in untransfected cells. Lanes 5 and 6 were exposed three times longer 
than lanes I to 4. (B) Association of ot-catenin with the E-cadherin/ 
catenin  complex after  expression  of E-cadherin,  ~-catenin,  and 
(tagged)/3-catenin  mutants lacking either the COOH-terminal do- 
main (lane  1)  or the NH2-terminal  domain (lane  2).  The com- 
plexes  were  co-immunoprecipitated  from  [35S]methionine-labeled 
extracts using anti-tag antibody.  (C) Association of APC to ct-cat- 
enin through linkage  by ~catenin.  Neuro2A cells  were cotrans- 
fected with expression  constructs for APC and u-catenin (lanes I 
and 2) or APC, ~catenin,  and/3-catenin without the COOH-ter- 
minal domain  (lane  3).  Immunoprecipitation from [35S]methio- 
nine-labeled  cell extracts was carried out using anti-APC (FLAG) 
(lane  1 and 3) or anti-c~-catenin  (lane  2) antibody.  (D)  Lack of 
homodimerization of ct-catenin. Neuro2A cells were cotransfected 
with expression  constructs for a-catenin, wild type/~-catenin and 
the tagged/3-catenin mutant lacking  the COOH-terminal domain. 
Immunoprecipitation  was performed  from [3~S]methionine-labeled 
cell extracts with anti-~-catenin antiserum (lane 1 ) or anti-tag anti- 
body (lane 2).  Note that the anti-~-catenin antiserum is directed 
against  an epitope in the COOH-terminal domain of ~-catenin. 
of the human APC gene encoding the/3-catenin-binding do- 
main (amino acid residues  958-1210;  Suet al.,  1993) was 
isolated, and an oligonucleotide encoding a synthetic epitope 
(FLAG) was ligated to the 5' end in order to detect the pro- 
tein immunologically. We found that the APC fragment also 
binds to the repeat units of/~-catenin and not the terminal do- 
mains (Fig. 4 A, lanes 2 and 3), and binding was again not 
confined to an individual repeat but rather to a region cover- 
ing multiple repeat units  (Fig.  4  A, lanes 3-7).  In contrast 
to E-cadherin, however, the NH2-terminal part of the repeat 
region (repeat units 1 to 10) is sufficient for binding to APC 
(Fig. 4 A, lane 4; see also Figs.  1 A and 7, for a summary). 
Interestingly, the APC-binding site of/~-catenin could not be 
reconstituted by any combination of non-binding mutants, as 
it was found for the interaction of the/3-catenin mutants with 
E-cadherin (Fig. 4 A, lane 9; cf. Fig. 3, A and B; and Hiil- 
sken,  J.,  unpublished results). 
The fact that both E-cadherin and APC bind to the repeat 
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molecule and the tumor suppressor gene product compete 
for binding to B-catenin. Thus, Neuro2A cells were cotrans- 
fected with constant amounts of expression constructs for 
APC and fl-catenin as well as with increasing amounts of the 
E-cadherin expression construct. Gradual increase of E-cad- 
herin expression indeed induced a redistribution of/3-catenin 
from APC to E-cadherin (Fig. 4 B). 
fl-Catenin Links ~-Catenin to E-Cadherin and APC 
We  have  found that  ~-catenin  directly interacts  with  the 
cytoskeleton-associated component ct-catenin,  as  revealed 
by co-immunoprecipitation after transfection of Neuro2A 
cells with expression constructs for both components (Fig. 
5  A,  lane 2).  ot-Catenin was  also  co-immunoprecipitated 
with mutants of/3-catenin lacking repeat units 8 to 13 and/or 
the COOH-terminal domain (Fig. 5 A, lanes 3 and 5), but 
clearly not with mutants lacking the NH2-terminal domain 
(Fig. 5 A, lanes 4 and 6). When a combination of E-cadhe- 
rin, ot-catenin,  and the (tagged) ~-catenin mutant lacking the 
COOH-terminal domain was expressed, anti-tag antibody 
immunoprecipitated a complex of all three components (Fig. 
5 B, lane 1); however, when the mutant of/3-catenin lack- 
ing the NH2-terminal domain was used, a complex without 
ot-catenin was  seen (Fig.  5 B, lane 2).  This indicates that 
ot-catenin does not directly interact with E-cadherin but in- 
directly through its interaction with/3-catenin (cf. also Fig. 
7). Accordingly, ot-catenin was only located at the cell mem- 
brane  when  coexpressed with  E-cadherin  and  /3-catenin, 
as revealed by immunofluorescence experiments (data not 
shown).  We also examined whether /3-catenin  mediates  a 
similar linkage between c~-catenin and APC. In fact, APC is 
only indirectly linked to c~-catenin via/3-catenin (Fig. 5 C). 
It has been suggested that c~-catenin forms homodimers 
through its domain with sequence similarity to the vinculin 
homodimerization  motif  (Nagafuchi  et  al.,  1991;  Her- 
renknecht et al.,  1991).  We analyzed this by expressing a 
combination of ct-catenin,  wild type /3-catenin  (without a 
tag), and the tagged mutant of/3-catenin lacking the COOH- 
terminal domain. Since our anti-/3-catenin antibody recog- 
nizes an epitope in the COOH-terminus,  we could distin- 
guish  the  complexes  c~-catenin/wild  type  /3-catenin  and 
o~-catenin//~-catenin  with COOH-terminal deletion (Fig.  5 
D). Apparently, ot-catenin does not homodimerize, since no 
quadruple complex (Bc~-c~Bmutant) was seen. 
Plakoglobin and B-Catenin Form Similar Complexes 
/3-Catenin and plakoglobin (3,-catenin) are structurally related 
consisting of central armadillo-like repeats flanked by NH:- 
and COOH-terminal domains (Franke et al., 1989; McCrea 
et al.,  1991; Knudsen and Wheelock,  1992). We therefore 
investigated whether plakoglobin may similarly form a com- 
plex with E-cadherin or APC. When a quadruple combina- 
tion of E-cadherin,  ~catenin,  ~catenin,  and plakoglobin 
was  expressed, anti-plakoglobin antibody immunoprecipi- 
tated a complex including E-cadherin and ~-catenin, but not 
B-catenin (Fig. 6 A, lane 1 ); conversely, anti-/3-catenin anti- 
body identified a complex containing E-cadherin and ot-cate- 
nin, but not plakoglobin (Fig. 6 A, lane 3). Plakoglobin also 
binds to o~-catenin in the absence of E-cadherin (Fig. 6 B, 
lane 2), but there was no direct association with/3-catenin 
(Fig. 6 B, lane 3). Furthermore, plakoglobin can also substi- 
tute for B-catenin in the APC complex (Fig. 6  C). These re- 
suits suggest that: (a) the structurally related molecules plako- 
globin (3,-catenin)  and B-catenin mediate binding between 
E-cadherin or APC and o~-catenin in two mutually exclusive 
complexes; and that (b) similar molecular interactions occur 
in plakoglobin- or B-catenin-containing complexes. 
Discussion 
We have here expressed the cDNAs of E-cadherin, APC, and 
three catenins (including various deletion mutants of/~-cate- 
nin) in the suitable expression system of Neuro2A cells. We 
could reconstruct the molecular interactions under condi- 
tions which closely resemble the in vivo situation. With anti- 
bodies against all the expressed proteins (the/3-catenin mu- 
tants and APC carried an added epitope), we were able to 
monitor the respective associations between these compo- 
nents by specific co-immunoprecipitation. Our data allow us 
to model the multiple interactions of/~-catenin which may 
occur within adherens junctions and the APC complex (Fig. 
7): B-catenin or plakoglobin directly interact with either the 
cell adhesion molecule E-cadherin or the tumor suppressor 
Figure 6.  (A) ~-Catenin and 
plakoglobin  form  distinct 
complexes  with  E-cadherin. 
Immunoprecipitations of psS]- 
methionine-labeled Neuro2A 
cells transfected with a combi- 
nation of  expression  constructs 
for  E-cadherin,  ot-catenin, 
B-catenin,  and  plakoglobin 
were  carried  out  with  anti- 
bodies  against  plakoglobin 
(lane 1 ), E-cadherin (lane 2), 
or/3-catenin (lane 3). The lo- 
cation of inununoprecipitated proteins is marked on the left. (B) Plakoglobin directly associates with c~-catenin. Immunoprecipitations 
with anti-plakoglobin antibody were performed from [3sS]methionine-labeled  cells transfected with expression constructs for c~-catenin 
and/~-catenin (control, lane 1 ), c~-catenin  and plakoglobin (lane 2), or ~/-catenin and plakoglobin (lane 3). (C) Association of APC with 
plakoglobin and linkage of c~-catenin  to APC through plakoglobin. Neuro2A cells were cotransfected with expression constructs for APC 
and plakoglobin (lane 1 ), or APC, ~catenin, and plakoglobin (lane 2). Immunoprecipitation from [35S]methionine-labeled  cell extracts 
was carried out using anti-APC  (anti-FLAG) antibody. 
The Journal of Cell Biology,  Volume 127, 1994  2066 Figure 7.  Schematic representation of the E-cadherin and APe 
complexes with/~-catenin or plakoglobin. B-Catenin/plakoglobin 
interact with the cytoplasmic region of the cell adhesion molecule 
E-cadherin via their internal armadillo-like repeats (drawn as links 
of a  chain), tx-Catenin, which mediates the  connection to the 
cytoskeleton, binds to the NH2-terminal  domain of B-catenin. No 
function has yet been assigned to the COOH-terminal domain of 
/3-catenin. ~Catenin/plakoglobin also interact with APC through 
the armadillo-like repeats. The three/~-catenin-binding repeats of 
APe (Suet al., 1993) are shown. We also indicate that the repeat 
units of B-catenin  may form an intramoleculax  loop and that the re- 
peats located more NH2- or COOH-terminally interact preferen- 
tially with APC or E-cadherin, respectively. 
gene product APC, and APC and E-cadherin actually com- 
pete for binding to the region of the internal, armadillo-like 
repeats  of B-catenin.  Furthermore,  B-Catenin  and plako- 
globin are direct linkers of both E-cadherin and APC to the 
cytoskeleton-associated protein  ot-catenin.  This  link  re- 
quires a distinct region of B-catenin, the NH2-terminal do- 
main. ~-Catenin and plakoglobin are thus centrally located 
in both the cell adhesion and the APC complexes, and it is 
also evident that the overall structural arrangement of the 
E-cadherin/catenin and the APC/catenin complexes is simi- 
lar (Fig.  7).  These findings indicate that/~-catenin/plako- 
globin represent important links in the communication be- 
tween  cell  adhesion,  cytoskeletal interaction,  and  tumor 
progression. 
There  exist  distinct differences,  however,  between  the 
E-cadherin/catenin and APC/catenin complexes.  No simi- 
larity in the primary structure between the catenin-binding 
region of E-cadherin or APC can be recognized (Suet al., 
1993).  Furthermore, we observed differences in the binding 
of B-catenin mutants to the cell adhesion molecule and the 
tumor suppressor gene product,  i.e., deletion of NH2- or 
COOH-terminal armadillo repeat units affected binding dif- 
ferently. Apparently, there exist two subregions within the 
repeat sequence of ~-catenin, to which E-cadherin and APC 
bind preferentially. Nevertheless, E-cadherin clearly com- 
petes with APC for the binding to B-catenin. Although we 
have not thoroughly studied binding affinities, it seems that 
E-cadherin binds more strongly, i.e., at comparable expres- 
sion levels of APC and E-cadherin, B-catenin is linked pri- 
marily to E-cadherin. Our finding that E-cadherin and APC 
bind to catenins in separate complexes is in line with previ- 
ous observations, i.e., the two components could not be co- 
immunoprecipitated (Suet al.,  1993). 
APC and E-cadherin are both involved in the suppression 
of neoplastic transformation and invasiveness (Fearon and 
Vogelstein, 1990;  Birchmeier et al.,  1993;  Behrens et al., 
1989; Frixen et al., 1991; Vleminckx et al., 1991); we might 
therefore speculate that both components cooperate in this 
function  via  the  competitive  interaction  with  /~-catenin. 
B-Catenin has been suggested to modulate E-cadherin-medi- 
ated cell adhesion during processes which require reduced 
cell adhesion, such as cytokinesis and cell movement, and 
tyrosine phosphorylation of/~-catenin interferes with E-cad- 
herin  function (Behrens  et  al.,  1993;  Hamaguchi et al., 
1993;  Shibamoto et al.,  1994).  APC could thus sequester 
negative regulatory variants of 15-catenin and prevent their 
interaction with E-cadherin. Alternatively, APC might di- 
rectly  interfere with  E-cadherin-mediated cell  adhesion, 
e.g., promote shedding of epithelial ceils into the colonic lu- 
men. As a correlate, APC expression has been found to in- 
crease from the base of the colonic crypts to the luminal sur- 
face (Smith et al., 1993). Absence or mutation of APC might 
thus promote progression of colon carcinomas by retention 
of proliferating cells, which then could collect further muta- 
tions known to contribute to the progression of colon  cancer 
(Fearon and Vogelstein,  1990).  It is generally accepted that 
E-cadherin regulates cytoskeletal organization through its 
interaction with the catenins (Ozawa et al.,  1990;  McNeill 
et al., 1990). The structural similarity of the E-cadherin and 
APC complexes could also indicate that APC exerts its tumor 
suppressor function through modulation of the cytoskeleton. 
APC has been detected in the 100,000 g insoluble membrane 
fraction  and  was  recently  found  to  be  associated  with 
microtubules (Smith et al., 1994; Munemitsu et al.,  1994). 
We have further demonstrated that plakoglobin can inter- 
act with either the cell adhesion molecule E-cadherin or the 
tumor suppressor gene product APC in the same manner as 
15-catenin. B-Catenin  and plakoglobin might thus be func- 
tionally redundant; this question can now be examined in 
systems where the gene for one or the other is deleted. Alter- 
natively, ~-catenin and plakoglobin might have functionally 
different roles and may be the subject of separate regulation. 
It is known that both proteins differ in their association with 
cell junctions in vivo,  i.e., B-catenin  is largely associated 
with adherens junctions whereas plakoglobin is also part of 
desmosomes  (Cowin  et  al.,  1986).  That  15-catenin and 
plakoglobin form mutually exclusive complexes with E-cad- 
herin  has  recently  also  been  suggested  by  Hinck  et  al. 
(1994a). 
Recent evidence suggests that/~-catenin, besides function- 
ing in adhesion complex formation and in the interaction 
with APC, is also involved in signal transduction: its homo- 
logue armadillo is part of a signal cascade from wingless (the 
vertebrate homologue is wnt-1) to engrailed in determining 
segment polarity in Drosophila (Bejsovec  and Wieschaus, 
1993; van Leeuwen et al., 1994).  Interestingly, overexpres- 
sion of wnt-1 in Xenopus embryos results in a duplication of 
the embryonic axis, and the same phenotype occurs after 
microinjection of anti-~-catenin antibody into  early  em- 
bryos (Sokol et al., 1991; McCrea et al., 1993), which sug- 
gests similar signalling events also during vertebrate devel- 
opment. In mammalian cells, it has been shown that wnt-1 
expression results in a strong accumulation of ~-catenin and 
plakoglobin at the cell membrane and in the strengthening 
of Ca2+-dependent adhesion (Bradley et al., 1993; Hinck et 
al., 1994a).  It remains to be determined whether these sig- 
nalling processes  make use of/~-catenin in a  membrane- 
associated  complex  or  whether  independent  interactions 
occur. 
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